SCHEMBL9348283

SCHEMBL9348283

O=c1c(CCCCO)c(O)c2cccnc2n1-c1cccc(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
CYP1A2 P05177 3/20 0.46
CYP2C19 P33261 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HPGD P15428 2/20 0.46
KDM4E B2RXH2 6/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPK1 P28482 1/20 0.41
TLR8 Q9NR97 1/20 0.40
CYP2C9 P11712 2/20 0.39
CYP2D6 P10635 1/20 0.39
PTGDR2 Q9Y5Y4 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GAA P10253 1/20 0.38
FEN1 P39748 1/20 0.38
PDE4A P27815 2/20 0.37
PDE4B Q07343 1/20 0.37
PDE4D Q08499 1/20 0.37
GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9348307 0.91 CYP1A2 (0.46) MAPTCYP1A2CYP2C19MEN1KMT2A
SCHEMBL9348174 0.89 MAPT (0.44) MAPTCYP1A2CYP2C19HPGDKDM4E
SCHEMBL10379180 0.88 KAT2B (0.42) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL9348282 0.88 FEN1 (0.50) MAPTCYP1A2CYP2C19HPGDKDM4E
SCHEMBL9348372 0.87 FEN1 (0.49) MAPTCYP1A2CYP2C19HPGDKDM4E
SCHEMBL10378879 0.87 SMN1; SMN2 (0.45) MAPTCYP1A2MEN1KMT2AALDH1A1
SCHEMBL9348332 0.86 MAPT (0.45) MAPTCYP1A2CYP2C19HPGDKDM4E
SCHEMBL9351651 0.85 KAT2B (0.43) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL9352330 0.84 FEN1 (0.51) MAPTCYP1A2CYP2C19HPGDKDM4E
SCHEMBL9352380 0.84 ALDH1A1 (0.46) MAPTCYP1A2CYP2C19MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5350755-A Treatment of psoriasis or eczema with naphthyridine derivative SCHERING CORPORATION (US) 1994-09-27 US disclosed
EP-0144996-B1 SUBSTITUTED SPIRO PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS AND COMPOSITIONS SCHERING CORPORATION (US) 1990-02-28 EP disclosed
US-4775524-A PSORIASIS SCHERING CORPORATION (US) 1988-10-04 US disclosed
US-4652564-A Substituted spiro pyridine derivatives as anti-allergy and antiinflammatory agents SCHERING CORPORATION (US) 1987-03-24 US disclosed
US-4632923-A Substituted hetero spiro pyridine derivatives as anti-allergy and anti-inflammatory agents SCHERING CORPORATION (US) 1986-12-30 US disclosed
EP-0144996-A2 Substituted spiro pyridine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions SCHERING CORPORATION (US) 1985-06-19 EP disclosed